InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Mogwai post# 95182

Friday, 11/04/2016 7:56:21 AM

Friday, November 04, 2016 7:56:21 AM

Post# of 427040
M-

It is highly unlikely AMRN will ever see $15 again. Even with 15% RRR it sure isn't gonna approach a $5b valuation.

Because ... ? A lot of other add-on drug with high RRR are available or 15% RRR is meaningless (acc. to you) or ...?

The "out of the ballpark" results are already out of the question since it wasn't stopped at interim.

Unless you are member of the DMC or get a first hand info from the DMC, you do not have any basis behind this. Stopping rule contains PE AND SEs and we do not know the exact reason behind continuation. PE (e.g. RRR 80%) does not overwrite the requirements for SEs.

They could have had $15-$20. $15 was a mere 25% premium from where it was trading so give me a break that they couldn't have gotten at least that if they wanted it. It was in the bag. ... Presumably because AMRN management wanted more than what a BP wanted to offer.

Once for all (not for you only). If any BP was really interested they could submit an offer. Management (JZ) claim does not matter, they could not refuse the submission. They could opine pro or cons about the offer, but the decision should be made by the shareholders. I am not aware of any officially submitted offer from anybody. Again:
- BO offer submission depends on potential buyer only, management could not stop it (refuse the submission)
- management could not refuse any offer, since it is the authority of shareholders

Best,
G

#STRONGERTOGETHER

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News